Nicholas J. Singer

Insider Reports History

Location
Miami, FL
Signature
/s/ Nicholas J. Singer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas J. Singer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. Director Common Stock 266,214 $660,211 $2.48 02 Dec 2022 By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer
Eterna Therapeutics Inc. Director Common Stock 121,822 $302,119 $2.48 02 Dec 2022 By Purchase Capital LLC
Eterna Therapeutics Inc. Director Warrants (right to buy) 424,928 $53,116 $0.1250 02 Dec 2022 By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer
Eterna Therapeutics Inc. Director Warrants (right to buy) 141,644 $17,706 $0.1250 02 Dec 2022 By Purchase Capital LLC
OTR Acquisition Corp. Chief Executive Officer, Director Class B Common Stock 421,759 20 May 2022 Indirect
Brooklyn ImmunoTherapeutics, Inc. Director Stock Option (right to buy) 165,800 01 Aug 2022 Direct
OTR Acquisition Corp. Chief Executive Officer, Director Class A Common Stock 0 20 May 2022 PC SPAC Holdings LLC
OTR Acquisition Corp. Chief Executive Officer, Director Class B Common Stock 0 20 May 2022 PC SPAC Holdings LLC
OTR Acquisition Corp. Chief Executive Officer, Director Warrants 0 20 May 2022 PC SPAC Holdings LLC

Insider Reports Filed by Nicholas J. Singer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ERNA Eterna Therapeutics Inc. 02 Dec 2022 4 +$1,000,000 4 Director 06 Dec 2022, 17:52
ERNA Brooklyn ImmunoTherapeutics, Inc. 01 Aug 2022 2 $0 4 Director 03 Aug 2022, 20:01
ERNA Brooklyn ImmunoTherapeutics, Inc. 05 Jun 2022 0 $0 3 Director 07 Jun 2022, 21:08
/report/000110465922063406-singer-nicholas-jason-2022-05-20 OTR Acquisition Corp. 20 May 2022 5 $0 4 Chief Executive Officer, Director 20 May 2022, 16:35
/report/000110465922057990-singer-nicholas-jason-2022-05-06 OTR Acquisition Corp. 06 May 2022 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 10 May 2022, 08:52